HAVANA (Reuters) – Cuba’s drug regulatory authority on Thursday approved a second COVID-19 vaccine candidate…
View More Cuba Approves Second Homegrown COVID Vaccine for Late Phase Trials
Home »
AstraZeneca Vaccine Protection Level Just 10% Against South African COVID-19 Variant
(Reuters Health) – The AstraZeneca COVID-19 vaccine developed with the University of Oxford has an…
View More AstraZeneca Vaccine Protection Level Just 10% Against South African COVID-19 Variant
States Prep for COVID-19 Vaccines for All Adults in May if Promised Supplies Arrive
(Reuters) – State public health departments are ready to begin giving COVID-19 shots to all…
View More States Prep for COVID-19 Vaccines for All Adults in May if Promised Supplies Arrive
Roche Launches COVID-19 Variant Test to Help Monitor Mutations
ZURICH (Reuters) – Roche is launching a SARS-CoV-2 variant test to help monitor emerging coronavirus…
View More Roche Launches COVID-19 Variant Test to Help Monitor Mutations
Online COVID-19 Symptom Checkers May Not Catch Severe Illnesses
NEW YORK (Reuters Health) – Digital COVID-19 symptom checkers in the U.S. and the U.K.…
View More Online COVID-19 Symptom Checkers May Not Catch Severe Illnesses
EU Drugs Regulator Clears J&J’s Single-Shot COVID-19 Vaccine
(Reuters) – The European Union’s drugs regulator on Thursday approved Johnson & Johnson’s single dose…
View More EU Drugs Regulator Clears J&J’s Single-Shot COVID-19 Vaccine
Spain: One Vaccine Dose to Under 55-Year-Olds Who Had COVID
MADRID (Reuters) – Spain will give a single vaccine dose to under 55-year-olds who have…
View More Spain: One Vaccine Dose to Under 55-Year-Olds Who Had COVID
UK Variant Not Causing Worse Illness in Children
(Reuters) – The coronavirus variant first identified in the UK does not cause more severe…
View More UK Variant Not Causing Worse Illness in Children